Near infrared fluorescence‐guided real‐time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green

Near infrared fluorescence‐guidance can be used for the detection of small cancer metastases and can aid in the endoscopic management of cancer. Indocyanine green (ICG) is a Food and Drug Administration (FDA)‐approved fluorescence agent. Through non‐specific interactions with serum proteins, ICG achieves enhanced permeability and retention (EPR) effects. Yet, ICG demonstrates rapid clearance from the circulation. Therefore, ICG may be an ideal contrast agent for real‐time fluorescence imaging of tumors. To evaluate the usefulness of real‐time dual fluorescence and white light endoscopic optical imaging to detect tumor implants using the contrast agent ICG, fluorescence‐guided laparoscopic procedures were performed in mouse models of peritoneally disseminated ovarian cancers. Animals were administered intravenous ICG or a control contrast agent, IR800‐conjugated to albumin. The ability to detect small ovarian cancer implants was then compared. Using the dual view microendoscope, ICG clearly enabled visualization of peritoneal ovarian cancer metastatic nodules derived from SHIN3 and OVCAR5 cells at 6 and 24 hr after injection with significantly higher tumor‐to‐background ratio than the control agent, IR800‐albumin (p < 0.001). In conclusion, ICG has the desirable properties of having both EPR effects and rapid clearance for the real‐time endoscopic detection of tiny ovarian cancer peritoneal implants compared to a control macromolecular agent with theoretically better EPR effects but longer circulatory retention. Given that ICG is already FDA‐approved and has a long track record of human use, this method could be easily translated to the clinic as a robust tool for fluorescence‐guided endoscopic procedures for the management and treatment of cancer.

[1]  C. S. Davidson,et al.  Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.

[2]  K. Baker,et al.  Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  K. Baker.  Binding of Sulfobromophthalein (BSP) Sodium and Indocyanine Green (ICG) by Plasma α1 Lipoproteins.∗ , 1966 .

[4]  R C Young,et al.  Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. , 1984, Seminars in oncology.

[5]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[6]  H. Hosick,et al.  Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen. , 1990, Oncology.

[7]  S. Noguchi,et al.  Sentinel Node Biopsy Guided by Indocyanin Green Dye in Breast Cancer Patients , 1999 .

[8]  S Noguchi,et al.  Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. , 1999, Japanese journal of clinical oncology.

[9]  V. Ntziachristos,et al.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[11]  M. Urashima,et al.  Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer , 2004, The British journal of surgery.

[12]  Robert M. Hoffman,et al.  The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.

[13]  Mitsuharu Miwa,et al.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer , 2005, Breast cancer.

[14]  Hisataka Kobayashi,et al.  A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A “Smart” Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases , 2007, Clinical Cancer Research.

[15]  Hisataka Kobayashi,et al.  Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. , 2007, Cancer research.

[16]  Marcelino Bernardo,et al.  A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. , 2007, Cancer research.

[17]  Milton V. Marshall,et al.  Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.

[18]  Osamu Ishikawa,et al.  Detection of Sentinel Node in Gastric Cancer Surgery by Indocyanine Green Fluorescence Imaging: Comparison with Infrared Imaging , 2008, Annals of Surgical Oncology.

[19]  P. Low,et al.  Folate receptor alpha as a tumor target in epithelial ovarian cancer. , 2008, Gynecologic oncology.

[20]  Hisataka Kobayashi,et al.  In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. , 2009, Cancer research.

[21]  Hisataka Kobayashi,et al.  Clinical implications of near-infrared fluorescence imaging in cancer. , 2009, Future oncology.

[22]  Wataru Fujimoto,et al.  Sentinel lymph node detection in skin cancer using fluorescence navigation with indocyanine green , 2009, The Journal of dermatology.

[23]  Hisataka Kobayashi,et al.  Toxicity of Organic Fluorophores Used in Molecular Imaging: Literature Review , 2009, Molecular imaging.

[24]  Hisataka Kobayashi,et al.  Real-time optical imaging using quantum dot and related nanocrystals. , 2010, Nanomedicine.

[25]  P. Choyke,et al.  New strategies for fluorescent probe design in medical diagnostic imaging. , 2010, Chemical reviews.

[26]  Kiyoshi Ono,et al.  Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer. , 2011, The Journal of thoracic and cardiovascular surgery.

[27]  Hiroshi Maeda,et al.  EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. , 2011, Advanced drug delivery reviews.